Press Releases
 
Prenatal Genetic Testing Market Revenue, Opportunity, Forecast 2017 - 2025

, 12 January 2018 -- Prenatal Genetic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Currently, in the Western world, political and biomedical systems largely define diseases and health as well as normality and abnormality. Prenatal genetic testing helps detect genetic problems or abnormalities before childbirth or during pregnancy term. A prenatal genetic test is performed to identify birth defects, which are related to syndromes or genetic disorders. The probability of having a birth defect or genetic disorder is likely to be due to a history of genetic disorders running in the parents’ or family’s history. Several genetic disorders or birth defects such as Trisomy 18 and Trisomy 13, and Down syndrome, are chromosome abnormalities that a child acquires by having an extra chromosome in the egg or sperm. Individuals with Down syndrome are disposed to mild mental retardation or cardiac disorder.

Increasing prevalence of genetic disorders such as Patau syndrome, Down syndrome, and Edward syndrome in prenatal is a key factor driving the prenatal genetic testing market. Rising demand for prenatal genetic testing for determining the ### of the fetus before 6 to 8 months gestation and identifying genetic abnormalities in prenatal are other factors that are propelling the prenatal genetic testing market.

Moreover, the prenatal genetic testing market is further driven by the increase in R&D activities related to proteomics and genomics, extensive presence of private and public organizations such as the Genomic Health Inc. and National Human Genome Research Institute (NHGRI), and development in technology. Rising methodologies for novel diagnostic technologies and tools and evolving genome profiling techniques such as TaqMan PCR are expected to boost the market at a rapid pace. Moreover, acquisition of small market entrants by leading players and high initial capital investments and strict government regulations for prenatal genetic tests are a few restraints for the prenatal genetic testing market.

The global prenatal genetic testing market can be segmented based on test type, end-user, and geography. Based on test type, the global prenatal genetic testing market can be classified into diagnostic tests and screening tests. Furthermore, the diagnostic tests segment can be further sub-segmented into chronic villi sampling (CVS), triple screen tests, non-invasive prenatal paternity test (NIPP), amniocentesis, placental biopsy, fetal biopsy, and cordocentesis. Moreover, the chronic villi sampling segment can be further split into trans abdominal chronic villi sampling and trans vaginal chronic villi sampling. Based on screening test, the prenatal genetic testing market can be segregated into maternal serum quad screening, sequential screening, and carrier screening. In terms of end user, the global prenatal genetic testing market can be segmented into hospitals, specialty clinics, and diagnostic centers.

Based on geography, the prenatal genetic testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North American dominates the global prenatal genetic testing market due to the presence of advanced technologies such as real-time PCR equipment and multiplex PCR technologies in the region. Moreover, favorable government policies toward proper screening of genetic abnormalities and diagnosis has fueled the prenatal genetic testing market in North America. Asia Pacific is a highly lucrative region for prenatal genetic testing market, due to the rapid development witnessed in the region.

Furthermore, emerging economies and easy market penetration in developing countries in Asia are anticipate to boost the prenatal genetic testing market in the near future. According to the Department of Health, Australia, nearly 5% of newborns in Australia have birth defects. This is a major factor boosting the prenatal genetic testing market in Asia Pacific. Moreover, improvements in healthcare services, development of various plans and policies of governments, rising awareness of genetic disease diagnosis, and rising economic development.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37841

Key players operating in the prenatal genetic testing market include Bio-Rad Laboratories Inc., Agilent Technologies Inc., Illumina, Inc., Natera Inc. Myriad Genetics, Inc., and PreventionGenetics.

# # #


Submitted by Sandy Researcher, Transparency Market Research on Friday, 12 January 2018 at 6:33 PM
Category: Health Care & Medical
 
Related News

Global Opportunity in the In Vitro Diagnostics Market is Expanding at a CAGR of 5.6% by 2025
Monday, 25 Jun 2018

Mobile Imaging Services Market – to Witness a Pronounce Growth by 2020
Monday, 25 Jun 2018

Atrial Fibrillation Market to Attain a Value of US$ 10,925.1 million by 2026
Monday, 25 Jun 2018

Physiotherapy Devices Market to Report a CAGR of 6.1% between 2017 – 2025
Monday, 25 Jun 2018

Catheters Market Opportunity will Rise to US$55.98 billion by 2025
Monday, 25 Jun 2018

Related Events

International Congress of the Royal College of Psychiatrists
Sunday, 24 Jun 2018

Innovation in Medicine 2018: RCP annual conference
Monday, 25 Jun 2018

26th Annual Primary Care Summer CME Conference
Monday, 25 Jun 2018

WIN Symposium 2018
Monday, 25 Jun 2018

The Scale-Up of Chemical Processes, Prague, Czech Republic
Monday, 25 Jun 2018

Latest News

Agent-Kr.com Helps Baccarat Lovers to Find the Best Online Baccarat Site to Play Safe
Tuesday, 26 Jun 2018

Recruiters Opting For Premium Job Posting With JobiSite Get Their Jobs Posted In Multiple Job Boards
Monday, 25 Jun 2018

Organizations in Hospitality Industry Flourishes under the Dynamic Leadership of Alexander Mirza
Monday, 25 Jun 2018

Tigerobo Raises over RMB 100 Million Series Pre-A to Create an Intelligent Financial Search Engine
Monday, 25 Jun 2018

Global Opportunity in the In Vitro Diagnostics Market is Expanding at a CAGR of 5.6% by 2025
Monday, 25 Jun 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 26 June 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • International Congress of the Royal College of Psychiatrists
  • Innovation in Medicine 2018: RCP annual conference
  • Electric Utility Cost Estimating 2018 Conference New Orleans, Louisiana
  • 26th Annual Primary Care Summer CME Conference
  • 27th World Gas Conference 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.